Cholera Vaccines Market 2017 to 2025 - Size, Share, Application Analysis, Regional Outlook, Growth Trends, Key Players, Competitive Strategies and Forecasts: Credence Research

According to the latest market report published by Credence Research, Inc. “Cholera vaccines Market was valued at US$ 51.3 Mn in 2016, and is expected to reach US$ 234.5 Mn by 2025, expanding at a CAGR of 15.8% from 2017 to 2025.
The purpose of the report is to illustrate the state of the market of Cholera Vaccines, to present actual information about the volumes of production, exports, imports, consumption and the state of the market, the changes that took place in 2017, and also, to build a forecast for the growth of the industry in the medium term until 2025.
Market Insights:
According to World Health Organization (WHO), there are roughly 1.3 to 4.0 million cholera cases, and 21,000 to 143,000 deaths worldwide each year due to cholera. The burden of cholera remains high globally, particularly in developing countries in Asia and Africa. Cholera prevention and treatment protocols are well established; government initiatives in immunization program is prime factor driving the market growth of cholera vaccines globally. For the purpose of study, the cholera vaccines market is segmented on the basis of product type such as Dukoral, Shanchol, Vaxchora and others; it is estimated that Vaxchora would grow significantly during forecast period because Vaxchora is the only vaccine available in the United States for protection against cholera and the only single dose vaccine for cholera currently licensed anywhere in the world. Centers for Disease Control and Prevention’s (CDC) and Advisory Committee on Immunization Practices (ACIP) recommended the use of Vaxchora in 18 to 64 years of age adults.
Browse here for full report with Toc: https://www.credenceresearch.com/report/cholera-vaccines-market
Leading Players:
The cholera vaccines market is observed to be highly competitive and comprises large number of players. However, the market is currently dominated by few players such as Astellas Pharma, Inc., PaxVax, Sanofi, Valneva, Eubiologics and other. 
Why was the report written?
This report is the result of an extensive survey drawn from Credence Research’s exclusive panel of leading global market industry executives; it provides data and analysis on buyer investment, acquisition, and developments within the global market research. It includes key topics such as global Cholera Vaccines buyer expenditure and procurement behaviors and strategies and recognizes the threats and possibilities within the industry, economic outlook trends, and business confidence within global industry executives. Most secondary research reports are based on general industry drivers and do not understand the industry executives’ attitude and changing behaviors, creating a gap in presenting the business outlook of the industry; in an effort to bridge this gap, Credence Research created this primary research-based report by gathering the opinions of multiple stakeholders in the value chain of the global industry.
Download Free Request Checkout: https://www.credenceresearch.com/checkout/58514
What is the current market landscape and what is changing?
Executives from the global industry anticipate an increase in levels of consolidation, with 55% of respondents projecting an increase in merger and acquisition (M&A) activities in 2017.
The report on the market of Cholera Vaccines contains:
Analysis and forecast of Cholera Vaccines market dynamics;
Analysis of domestic production, market shares of the main market players;
Analysis of exports and imports;
Analysis of factors, leading the development of the Cholera Vaccines market;
Assessment and forecast of Cholera Vaccines market development;
Financial and business profiles of the leading companies in the Cholera Vaccines industry.
Also you can request us for sample in pdf with more details and graph: https://www.credenceresearch.com/sample-request/58514
Scope
- Up to date working Cholera Vaccines data by major regions in the world, the forecast of planned capacity additions by 2026
- The annual breakdown of capital expenditure spending on proposed Cholera Vaccines for the period 2018 to 2026
- Planned Cholera Vaccines additions and capital expenditure spending by key countries and companies across the world
- Planned capital expenditure spending on new Cholera Vaccines projects by region, key countries, and companies
- Details of major planned Cholera Vaccines projects in the world up to 2026
 Our Blog: http://www.mobilecomputingtoday.co.uk/5696/cholera-vaccines-market-expected-reach-1341-8-2025-credence-research/